Sanofi Statistics
Total Valuation
Sanofi has a market cap or net worth of 137.91 billion. The enterprise value is 156.84 billion.
| Market Cap | 137.91B |
| Enterprise Value | 156.84B |
Important Dates
The next estimated earnings date is Friday, October 25, 2024.
| Earnings Date | Oct 25, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
| Shares Outstanding | n/a |
| Shares Change (YoY) | -0.04% |
| Shares Change (QoQ) | +0.80% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 1.10B |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | n/a |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 11.95, with an EV/FCF ratio of 23.49.
| EV / Earnings | 34.72 |
| EV / Sales | 3.04 |
| EV / EBITDA | 11.95 |
| EV / EBIT | 16.99 |
| EV / FCF | 23.49 |
Financial Position
The company has a current ratio of 1.00, with a Debt / Equity ratio of 0.33.
| Current Ratio | 1.00 |
| Quick Ratio | 0.52 |
| Debt / Equity | 0.33 |
| Debt / EBITDA | 1.97 |
| Debt / FCF | 3.81 |
| Interest Coverage | 14.02 |
Financial Efficiency
Return on equity (ROE) is 5.81% and return on invested capital (ROIC) is 5.57%.
| Return on Equity (ROE) | 5.81% |
| Return on Assets (ROA) | 4.16% |
| Return on Capital (ROIC) | 5.57% |
| Revenue Per Employee | 585,966 |
| Profits Per Employee | 52,473 |
| Employee Count | 86,088 |
| Asset Turnover | 0.37 |
| Inventory Turnover | 1.43 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +2.02% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +2.02% |
| 50-Day Moving Average | 109.84 |
| 200-Day Moving Average | 100.53 |
| Relative Strength Index (RSI) | 37.16 |
| Average Volume (20 Days) | 36,163 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Sanofi had revenue of 50.44 billion and earned 4.52 billion in profits. Earnings per share was 3.60.
| Revenue | 50.44B |
| Gross Profit | 34.69B |
| Operating Income | 9.10B |
| Pretax Income | 5.98B |
| Net Income | 4.52B |
| EBITDA | 12.59B |
| EBIT | 9.10B |
| Earnings Per Share (EPS) | 3.60 |
Balance Sheet
The company has 7.28 billion in cash and 25.45 billion in debt, giving a net cash position of -18.17 billion.
| Cash & Cash Equivalents | 7.28B |
| Total Debt | 25.45B |
| Net Cash | -18.17B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 78.21B |
| Book Value Per Share | 62.26 |
| Working Capital | 57.86M |
Cash Flow
In the last 12 months, operating cash flow was 8.70 billion and capital expenditures -2.02 billion, giving a free cash flow of 6.68 billion.
| Operating Cash Flow | 8.70B |
| Capital Expenditures | -2.02B |
| Free Cash Flow | 6.68B |
| FCF Per Share | n/a |
Margins
Gross margin is 68.77%, with operating and profit margins of 18.04% and 8.95%.
| Gross Margin | 68.77% |
| Operating Margin | 18.04% |
| Pretax Margin | 11.85% |
| Profit Margin | 8.95% |
| EBITDA Margin | 24.97% |
| EBIT Margin | 18.04% |
| FCF Margin | 13.23% |
Dividends & Yields
Sanofi does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 111.57% |
| Buyback Yield | 0.04% |
| Shareholder Yield | 0.04% |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |